Ardelyx Inc
ARDX
$3.88+3.61%
Delayed · as of Aug 25, 2026, 10:59 AM ET
Mkt cap
$1.37B
EV/Sales
3.70
P/E ratio
N/A
FY2025 Revenue
$407.32M
EPS (TTM)
$-0.23
Gross Margin (FY2025)
90.29%
Profit Margin (FY2025)
-15.12%
Beta
0.58
Div yield
N/A
Sector
Healthcare
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Latest reported ARDX revenue for 2025-12-31 was $407.3M. Net income was -$61.6M. Revenue was up 22.1% from 2024-12-31 to 2025-12-31. ARDX currently screens at market cap $1.37B.
Use this ARDX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ARDX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Ardelyx Inc (ARDX) is a biotechnology company in the Healthcare sector.
Latest cached Ardelyx Inc (ARDX) revenue for Dec 31, 2025 was $407.3M. Net income was -$61.6M. Statements: https://lician.com/financials/ardx
Ardelyx Inc (ARDX) market capitalization is $1.37B on the latest cached snapshot.
Ardelyx Inc (ARDX) cached previous close $3.74; day range $3.75 – $3.93; volume 736,292. Session quote: https://lician.com/quote/ardx
Ardelyx Inc (ARDX) latest cached earnings event is "ARDX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ARDX filing is 8-K · Aug 17, 2026. Filings: https://lician.com/sec/ardx